Applications Published 19 September 2001
Published: 17-May-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Biocide material and method of preparation of said material
Eastman Kodak 1133228* Pharmaceutical aerosol compsn containing HFA 227 and HFA 134A
Chiesi Farmaceutici 1133277*Delivery of liposomal-encapsulated antioxidants and applications thereof
Her Majesty the Queen as represented by the Minister of National Defence of Her Majesty's Canadian Government 1133278*Method of producing vitamin powders
Archer-Daniels-Midland 1133279*Method of preparing stable suspensions of insoluble microparticles
RTP Pharma 1133281*Taste masking rapid release coating system
Cima Labs 1133282*A method of producing drug particles
AstraZeneca 1133283*New process
AstraZeneca 1133284*A process for producing particles with a converted amorphous and/or metastable crystalline region into a crystalline state
AstraZeneca 1133285*Solid lipidic nanospheres suitable to a fast internalisation into cells
Gasco, Maria Rosa 1133286*Use of 17-ketosteroids for the treatment of hepatitis C virus and other togaviruses Hollis-Eden Pharmaceuticals;
Colthurst 1133287*The use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence
Knoll 1131288*Use of fumarate salt of L-carnitine or its alkanoyl derivatives in ischaemia
Sigma-Tau 1133289*Use of effectors of the central cholinergic nervous system
Sanochemia Pharmaceutika 1133290*Methods of treating thrombocytopenia
SmithKline Beecham 1133291*A new pharmaceutical formulation
AstraZeneca 1131292*Use of N-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
BASF 1133293*Compsns and methods for the treatment of Alzheimer's disease, central nervous system injury and inflammatory diseases
Case Western Reserve University 1133294*Use of nicergoline for treating spasmodism
Aventis Pharma 1133295*Novel therapeutic application of nicergoline
Aventis Pharma 1133296*Novel therapeutic use of 1m6-dimethyl-8beta-hydromethyl0-10alpha-methoxygoline
Aventis Pharma 1133297*Compsns comprising cefuroxime axetil
Biochemie 1133298*2-hydroxymethylolanzapine compsns and methods
Sepracor 1133299*Desmethylolanzapine compsns and methods
Sepracor 1133300*Anti-asthmatic combinations comprising surface active phospholipids
Britannia Pharmaceuticals 1133301*Use ofphsophonoformic acid derivatives for treating infections
Jomaa Pharmaka 1133302*
